#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypocalcaemia B-cell lymphoma Acute lymphocytic leukaemia Cutaneous calcification Heritable pulmonary arterial hypertension Rectal cancer Immune-mediated myasthenia gravis Cutaneous T-cell lymphoma stage I Marginal zone lymphoma refractory Oesophageal squamous cell carcinoma stage III Acquired ATTR amyloidosis Leukocyte adhesion deficiency type I Corneal neovascularisation Glomerulonephritis minimal lesion Scedosporium infection More trials…

    Learn about Rare Diseases

    Synovial sarcoma recurrent – Trials in Disease Osteosarcoma Carcinoid syndrome – Treatment Combined immunodeficiency – Basic Information Progressive supranuclear palsy – Basic Information Small intestine leiomyosarcoma Pleomorphic leiomyosarcoma – Trials in Disease Retinitis pigmentosa – Basic Information Toxic epidermal necrolysis – Treatment Cystic fibrosis lung More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    R-Azasetron Besilate Promazine Hydrochloride Abiraterone Rondaptivon Pegol Nimotuzumab Carbamazepine (Ph. Eur.) Lomustine Solrikitug Buloxibutid Quc398 Pimozide XMAB942 Sar441566 Degarelix Ziftomenib Riluzole Bimekizumab Avalglucosidase Alfa Goserelin Acetate Elezanumab More therapies…

    Learn about Your Condition

    Oesophageal carcinoma Cardiac arrest Adrenocortical carcinoma Breast cancer metastatic Peripheral artery thrombosis Nephrogenic anaemia Glomerulonephritis chronic Hyperhidrosis KBG syndrome Diabetes mellitus Anorexia nervosa Albuminuria Prostate cancer Onychomycosis C3 glomerulopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Osteosarcoma

  • Cabozantinib Maintenance Therapy vs Best Supportive Care in Osteosarcoma Patients in Complete Remission or with Residual Disease after First‑Line Chemotherapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cabozantinib
    Denmark Finland France Italy The Netherlands Poland +2

  • A study comparing mifamurtide to sorafenib for treating high-risk osteosarcoma in children and young adults

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteosarcoma
    Investigated Drugs:
    • Mifamurtide
    • Sorafenib
    Poland

  • Long-term safety study of GD2IL18CART treatment in patients with neuroblastoma, osteosarcoma, Ewing sarcoma, or advanced breast cancer

    Recruiting

    1 1 1
    Investigated Drugs:
    • Gd2Il18Cart
    Germany

  • Study on the Safety and Dosage of GD2IL18CART for Patients with Relapsed or Refractory GD2 Positive Solid Cancers

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Clemastine Fumarate
    • Gd2Il18Cart
    • Anakinra
    Germany

  • Study of Trabectedin and Low-Dose Radiation Therapy for Adults and Young Adults with Advanced or Metastatic Soft Tissue and Bone Sarcomas

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chondrosarcoma
    • Sarcoma
    • Desmoplastic small round cell tumour
    Investigated Drugs:
    • Trabectedin
    • Irinotecan Hydrochloride Trihydrate
    Spain

  • Study on Mifamurtide with Chemotherapy for Patients with High-Risk Osteosarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteosarcoma metastatic
    • Osteosarcoma
    Investigated Drugs:
    • Mifamurtide
    • Ifosfamide
    • Doxorubicin Hydrochloride
    France
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!